Christopher Posner, President and CEO at Cara Therapeutics, Inc. (CARA), sold 28,940 shares at $11.13 ($322K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Open-market sale of $322k CARA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.13 | 14,470 | $161K | 50.0% |
| 2 | $11.13 | 14,470 | $161K | 50.0% |
| Total | $11.13 avg | 28,940 | $322K | 100% |
| Filing → |
| CARA | SELL | 2024-11-06 | $1K | — | Filing → |
| CARA | SELL | 2024-08-02 | $1K | — | Filing → |
| CARA | SELL | 2024-05-06 | $3K | — | Filing → |